申请人:GUANGDONG RAYNOVENT BIOTECH CO., LTD.
公开号:US10278973B2
公开(公告)日:2019-05-07
Disclosed are a series of hydroxyl purine compounds and the use thereof as PDE2 or TNFα inhibitors, in particular, the compounds as shown in formula (I), or tautomers thereof or pharmaceutically acceptable salts thereof.
公开了一系列羟基嘌呤化合物及其作为 PDE2 或 TNFα 抑制剂的用途,特别是如式 (I) 所示的化合物或其同系物或其药学上可接受的盐。